Immunome, Inc. (NASDAQ: IMNM) shares fell sharply by 9.6% following the announcement of the pricing of its upsized public offering of common stock. The biotechnol ...
Dover , a diversified global manufacturer, announced its financial results for the fourth quarter and full year ended December 31, 2024. All comparisons are to the comparable period of the prior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback